Toxemia: all 933 studies

Page 9 of 10. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.

• Comparison the Value of Several Biomarkers of SepsisCompletedNCT01388725
• SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICUCompletedNCT01378169
• Hypertensive Disorders of Pregnancy in Adolescence and PrimipaternityStatus unknownNCT01374477
• Plasma Inducible Nitric Oxide Synthase (iNOS) Assay and Sepsis StudyTerminatedNCT01371929
• Exercise in Critically Ill Patients With SepsisStatus unknownNCT01364909Not applicable
• Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen SaturationCompletedNCT01362829
• Pro-adrenomedullin as a Prognostic Marker in Neonatal SepsisCompletedNCT01362504
• Neonatal Sepsis, Evaluation, BangladeshCompletedNCT01333982Not applicable
• The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney InjuriesCompletedNCT01333657
• Microcirculatory Changes During Magnesium Sulphate Infusion in SepsisCompletedNCT01332734
• Zinc and Inflammation in SepsisCompletedNCT01328509
• The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock PatientsCompletedNCT01319630
• GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic ShockTerminatedNCT01315496Phase 3
• Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Late-onset Neonatal SepsisStatus unknownNCT01294865
• Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)CompletedNCT01284452Not applicable
• The Effect of Moderate-Dose Steroid Therapy in SepsisCompletedNCT01275638Phase 4
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe SepsisSuspendedNCT01273779Phase 2/3
• Hypertonic Saline and Terlipressin for Sepsis-associated HypotensionTerminatedNCT01271114Phase 3
• Pilot Study: Lactoferrin for Prevention of Neonatal SepsisCompletedNCT01264536Phase 2
• The Prediction of Preeclampsia/Toxemia in Twin PregnancyStatus unknownNCT01255202
• End-of-life Decision-making in Patients With Sepsis-related Organ FailureCompletedNCT01247792Not applicable
• Hyperinsulinemic Therapy in SepsisStatus unknownNCT01244178Not applicable
• Hematological Infection Score Compared to the Hospital Standard for Diagnosis of SIRS or Sepsis on ICUCompletedNCT01236703
• Clarithromycin as Immunomodulator for the Management of SepsisCompletedNCT01223690Phase 3
• Probiotics for Prevention Neonatal InfectionTerminatedNCT01214473Not applicable
• 4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic ShockStatus unknownNCT01211899
• MiRNAs Evaluate the Prognosis of SepsisStatus unknownNCT01207531
• Medical Education for Sepsis Source Control and AntibioticsCompletedNCT01187134Not applicable
• Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)Status unknownNCT01169168
• Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 AdjuvantTerminatedNCT01164514Phase 1
• Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)CompletedNCT01139489Not applicable
• Indicators of Inflammation and Coagulation in SepsisCompletedNCT01128283
• Improved Detection of Neonatal Sepsis Using a Targeted Biomarker AssayCompletedNCT01120678
• The Effect of Erythropietin on Microcircualtory Alteration in Intensive Care Unit Patients With Severe SepsisTerminatedNCT01087450
• Mild Therapeutic Hypothermia During Severe SepsisCompletedNCT01069146Not applicable
• Cerebrovascular Autoregulation During SepsisCompletedNCT01029080
• Simplified Antibiotic Therapy for Sepsis in Young InfantsCompletedNCT01027429Phase 3
• Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious InfectionTerminatedNCT01025180Phase 4
• Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic ControlCompletedNCT01013662Not applicable
• Coagulation Factors, Cytokines and Tissue Injury Markers in SepsisCompletedNCT01012115
• Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'Status unknownNCT01006499Phase 4
• The Effects of Metformin on Pregnancy and Miscarriage Rates in Polycystic Ovary Syndrome (PCOS)CompletedNCT00994812Phase 3
• Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICUWithdrawnNCT00987818Not applicable
• Australasian Resuscitation In Sepsis Evaluation Randomised Controlled TrialStatus unknownNCT00975793Phase 3
• Scandinavian Starch for Severe Sepsis/Septic Shock TrialCompletedNCT00962156Phase 3
• The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Multiple Organ Dysfunction Syndrome (MODS)Status unknownNCT00908635
• Hepatic Mitochondrial Function in SepsisWithdrawnNCT00889083
• Early-Onset Sepsis Surveillance StudyCompletedNCT00874367
• Circulating microRNAs as Biomarkers of SepsisCompletedNCT00862290
• Neonatal Sepsis and GBS Carriage StudyCompletedNCT00861055
• Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in BangladeshCompletedNCT00844337Not applicable
• The Ohio State University Sepsis RegistryTerminatedNCT00837421
• Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney InjuryStatus unknownNCT00837057Phase 4
• Autonomic Nervous System Alteration Induce by Sepsis: Assessment and Prognosis ImpactCompletedNCT00835913
• Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and SepsisTerminatedNCT00835874Not applicable
• Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe SepsisCompletedNCT00832039Phase 3
• Fluid Resuscitation in Early Septic ShockCompletedNCT00819416Phase 2
• Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU PatientsCompletedNCT00811629
• Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid LeukemiaCompletedNCT00806325
• The Biomarker and Cardiac Function in SepsisStatus unknownNCT00800631
• Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe SepsisCompletedNCT00799916Phase 3
• Endothelium in Severe SepsisCompletedNCT00793442
• Evaluation of MorphoTEP With the FDG Among Patients in Severe Sepsis of Unspecified EtiologyStatus unknownNCT00791310Phase 3
• Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological PatientsCompletedNCT00781040
• Septic Encephalopathy and Late Cognitive DysfunctionCompletedNCT00772096Phase 4
• Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis - a Randomised Pilot StudyCompletedNCT00732277Phase 2
• Efficacy of Thymosin alpha1 for Severe SepsisCompletedNCT00711620Not applicable
• Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing EnterocolitisCompletedNCT00707785Phase 3
• Volume Replacement With Albumin in Severe SepsisCompletedNCT00707122Phase 3
• Evaluation of the Patient Safety Screening Tool (PSST) for SepsisTerminatedNCT00698542
• Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic ShockCompletedNCT00698048
• Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis PatientsStatus unknownNCT00697944Phase 4
• Acute Phase Proteins as Early Markers in SepsisStatus unknownNCT00641355
• Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe SepsisCompletedNCT00634075Phase 4
• Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe SepsisCompletedNCT00630656Phase 2
• L-citrulline Supplementation During SepsisStatus unknownNCT00628381Phase 3
• Relationship Between Alcohol Use Disorders and Cortisol Levels in Patients With SepsisCompletedNCT00615862
• Muscle Atrophy in SepsisWithdrawnNCT00583206
• The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of DeathCompletedNCT00568737Phase 3
• A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in AdultSuspendedNCT00563134Not applicable
• Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting SepsisCompletedNCT00561639
• Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With SepsisCompletedNCT00559130Not applicable
• Skeletal Muscle and Platelet Mitochondrial Dysfunction During SepsisCompletedNCT00541827
• Cytokine Removal by CRRT in Pediatric SepsisCompletedNCT00537693Not applicable
• Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic ShockCompletedNCT00534287Phase 3
• A Study in Sepsis Patients With Renal FailureTerminatedNCT00511186Phase 2
• Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)CompletedNCT00488917
• Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular CoagulationCompletedNCT00487656Phase 2
• Methylene Blue in Sepsis: A Randomized Controlled TrialWithdrawnNCT00486174Not applicable
• Alterations of Immunologic Mediators During Severe SepsisTerminatedNCT00484146
• Microcirculation Guided Therapy Versus "Standard Treatment" of Severe SepsisStatus unknownNCT00484133Phase 4
• Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)WithdrawnNCT00472628
• Pharmacokinetic of Ceftriaxone in Septic ICU PatientsStatus unknownNCT00449800Phase 4
• The Utility of Ischemia Modified Albumin (IMA) in SepsisCompletedNCT00448968
• Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With SepsisCompletedNCT00430859Phase 2
• Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe SepsisCompletedNCT00406198Phase 4
• Sepsis: Prognosis and Evaluation of Early Diagnosis and Intervention (SPEEDI Study)Status unknownNCT00389337
• Clinical Trial of the Optimal Endpoint of Early Sepsis ResuscitationCompletedNCT00372502Not applicable
• Effect of Rosuvastatin in Abdominal SepsisStatus unknownNCT00357123Phase 2
• The Effects of HIV Protease Inhibitors in Severe SepsisCompletedNCT00346580Phase 1

← Toxemia overview